Blog | HemaCare

"Breathing" Helps Your CD8 T cells Get Rid of Infections and Cancer.

Jan 6, 2016 8:00:13 PM / by Dalia Gaddis posted in proliferation, Cancer, Cancer Immunology, infection, Innovation, mitochondria, research, respiration

0 Comments

Researchers discover a new protein that increases respiration in CD8+ cytotoxic T cells, making them superior killers against virus-infected and cancer cells.

The saying goes when things get tough, take a deep breath. While this relaxation technique protects our health, apparently it also improves our immune system functions. Scientists discovered a new protein that increases the respiration of CD8 cytotoxic T cells, making them more fit to fight chronic infections and cancer.

Read More

Quality Tregs: HemaCare Develops a New Treg Enrichment Protocol

Apr 27, 2015 1:00:12 PM / by Maria posted in biomarkers, Cancer, immune system, infection, Innovation, research

0 Comments

Enriched Tregs prepared by HemaCare are useful for a multitude of research applications

Read More

Drug Screening in Healthy and Diseased PBMCs

Jan 22, 2014 2:32:37 PM / by Maria posted in drug screening, PBCs, proliferation, apoptosis, drug development, Drug Discovery, infection, Inflammation, Innovation, migration, PBMCs, Peripheral blood cells, peripheral blood mononuclear cells, research, viability

0 Comments

Peripheral Blood Mononuclear Cells (PBMCs) can be used in drug screening.  In Part I from this series, we discussed how they can be used to assay drug activity including effects on proliferation, viability, apoptosis, inflammation, and migration in healthy and disease cell models.  There are related assays available to measure the effects of drug treatment and, especially for researchers that prefer to use human samples, peripheral blood mononuclear cells are often the cells of choice (PBMCs) are often the cells of choice.  The advantages of using human cells initially are immense.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts